Slobodan Rendić

3.9k total citations · 3 hit papers
45 papers, 3.2k citations indexed

About

Slobodan Rendić is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Slobodan Rendić has authored 45 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmacology, 16 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Slobodan Rendić's work include Pharmacogenetics and Drug Metabolism (28 papers), Drug Transport and Resistance Mechanisms (15 papers) and Analytical Chemistry and Chromatography (6 papers). Slobodan Rendić is often cited by papers focused on Pharmacogenetics and Drug Metabolism (28 papers), Drug Transport and Resistance Mechanisms (15 papers) and Analytical Chemistry and Chromatography (6 papers). Slobodan Rendić collaborates with scholars based in Croatia, United States and Germany. Slobodan Rendić's co-authors include Frederick J. Di Carlo, F. Peter Guengerich, F. KAJFEŽ, Hans-Heinrich Ruf, Roberto Dal Toso, Tanja Alebić-Kolbah, Vitomir Šunjić, Wilhelm Schänzer, Günther Snatzke and P. Weber and has published in prestigious journals such as Biochemical Pharmacology, Journal of Pharmaceutical Sciences and Clinica Chimica Acta.

In The Last Decade

Slobodan Rendić

43 papers receiving 3.0k citations

Hit Papers

Human Cytochrome P450 Enzymes: A Status Report Summarizin... 1997 2026 2006 2016 1997 2002 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Slobodan Rendić Croatia 20 2.1k 972 870 419 369 45 3.2k
Kenneth R. Korzekwa United States 34 2.7k 1.3× 1.2k 1.2× 1.1k 1.3× 658 1.6× 430 1.2× 63 3.9k
Larry C. Wienkers United States 33 2.6k 1.2× 1.2k 1.3× 947 1.1× 571 1.4× 551 1.5× 79 3.9k
Ken Korzekwa United States 27 2.2k 1.0× 1.6k 1.6× 937 1.1× 461 1.1× 267 0.7× 67 3.4k
Robert L. Walsky United States 25 1.8k 0.8× 927 1.0× 666 0.8× 370 0.9× 318 0.9× 35 2.7k
Richard Weaver United Kingdom 36 1.7k 0.8× 1.2k 1.2× 1.2k 1.3× 386 0.9× 329 0.9× 86 3.9k
Lance R. Pohl United States 44 3.1k 1.5× 986 1.0× 1.2k 1.4× 312 0.7× 554 1.5× 114 5.4k
A. David Rodrigues United States 33 1.8k 0.9× 1.1k 1.2× 619 0.7× 250 0.6× 406 1.1× 68 3.0k
Mayumi Mimura Japan 19 2.5k 1.2× 1.3k 1.3× 718 0.8× 216 0.5× 378 1.0× 39 3.7k
Thomas Friedberg United Kingdom 35 1.8k 0.8× 961 1.0× 1.5k 1.7× 225 0.5× 227 0.6× 83 3.5k
Barbara J. Ring United States 36 2.7k 1.3× 1.5k 1.5× 1.0k 1.2× 625 1.5× 641 1.7× 59 4.7k

Countries citing papers authored by Slobodan Rendić

Since Specialization
Citations

This map shows the geographic impact of Slobodan Rendić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slobodan Rendić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slobodan Rendić more than expected).

Fields of papers citing papers by Slobodan Rendić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Slobodan Rendić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slobodan Rendić. The network helps show where Slobodan Rendić may publish in the future.

Co-authorship network of co-authors of Slobodan Rendić

This figure shows the co-authorship network connecting the top 25 collaborators of Slobodan Rendić. A scholar is included among the top collaborators of Slobodan Rendić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Slobodan Rendić. Slobodan Rendić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rendić, Slobodan & F. Peter Guengerich. (2024). Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes. Archives of Toxicology. 98(6). 1581–1628. 7 indexed citations
2.
Rendić, Slobodan, et al.. (2022). Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions. Archives of Toxicology. 96(8). 2145–2246. 24 indexed citations
3.
Rendić, Slobodan. (2021). Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects. Archives of Toxicology. 95(5). 1535–1546. 36 indexed citations
4.
Rendić, Slobodan & F. Peter Guengerich. (2014). Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals. Chemical Research in Toxicology. 28(1). 38–42. 354 indexed citations breakdown →
5.
Rendić, Slobodan & F. Peter Guengerich. (2012). Summary of Information on the Effects of Ionizing and Non-ionizing Radiation on Cytochrome P450 and Other Drug Metabolizing Enzymes and Transporters. Current Drug Metabolism. 13(6). 787–814. 31 indexed citations
6.
Guengerich, F. Peter & Slobodan Rendić. (2010). Update Information on Drug Metabolism Systems— 2009, Part I. Current Drug Metabolism. 11(1). 1–3. 38 indexed citations
7.
Rendić, Slobodan. (2004). Strategies for more effective and reliable ADME. Expert Opinion on Drug Safety. 3(4). 379–380. 1 indexed citations
8.
Rendić, Slobodan, et al.. (1999). Metabolism of anabolic steroids by recombinant human cytochrome P450 enzymes. Journal of Chromatography B Biomedical Sciences and Applications. 735(1). 73–83. 46 indexed citations
9.
Rendić, Slobodan & Frederick J. Di Carlo. (1997). Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors. Drug Metabolism Reviews. 29(1-2). 413–580. 966 indexed citations breakdown →
10.
Medič-Šarić, Marica, et al.. (1994). Binding of (+)- and (-)-Isomers and Racemate of Etomoxir to Human Serum Albumin and Effect of Stearic Acid and Stanozolol. Journal of Pharmaceutical Sciences. 83(4). 485–490. 4 indexed citations
11.
Rendić, Slobodan, et al.. (1994). Urinary excretion and metabolism of orally administered mefenorex. European Journal of Drug Metabolism and Pharmacokinetics. 19(2). 107–117. 6 indexed citations
12.
Nikolić, Sonja, Marica Medič-Šarić, Slobodan Rendić, & Nenad Trinajstić. (1994). Toxic Effects and a Structure-Property Study of Organic Explosives, Propellants, and Related Compounds. Drug Metabolism Reviews. 26(4). 717–738. 10 indexed citations
13.
Catlin, Don H., David J. Neep, M. Donike, et al.. (1992). Testing urine for drugs. Journal of Analytical Methods in Chemistry. 14(3). 85–92. 4 indexed citations
14.
Catlin, Don H., David J. Neep, M. Donike, et al.. (1992). Testing urine for drugs. Clinica Chimica Acta. 207(3). S13–S26. 11 indexed citations
15.
Rendić, Slobodan & Hans-Heinrich Ruf. (1988). Interaction of stanozolol with cytochrome P-450. Biochemical Pharmacology. 37(4). 766–768. 6 indexed citations
16.
Rendić, Slobodan, F. KAJFEŽ, & Hans-Heinrich Ruf. (1983). Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450.. Drug Metabolism and Disposition. 11(2). 137–142. 108 indexed citations
17.
Schulte, K. E., et al.. (1978). Malimide: A urinary metabolite of succinimide in the rat. European Journal of Drug Metabolism and Pharmacokinetics. 3(4). 249–250. 3 indexed citations
18.
Rendić, Slobodan, et al.. (1975). Mass spectrometry of 1,4-benzodiazepines. Journal of Mass Spectrometry. 2(2). 97–106. 15 indexed citations
19.
Rendić, Slobodan, et al.. (1974). カイラルと非カイラルな1,3-ジヒドロ-2H-1,4-ベンゾジアゼピン-2-オンの酵素による生化学的変換の立体特異性. CHIMIA International Journal for Chemistry. 28(5). 232–234. 2 indexed citations
20.
Rendić, Slobodan, et al.. (1974). Stereoselectivity in Enzymic Biotransformation of Chiral and Achiral 1,3-Dihydro-2H-1,4-Benzodiazepin-2-ones. CHIMIA International Journal for Chemistry. 28(5). 232–232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026